Form 4: AtriCure Executive Karl S. Dahlquist Acquires Shares Through Employee Stock Purchase Plan

Chief Legal Officer Karl S. Dahlquist acquired 707 shares of AtriCure, Inc. through the company's Employee Stock Purchase Plan (ESPP) at a discounted price of $19.35 per share.

Summary

• On June 28, 2024, Karl S. Dahlquist, Chief Legal Officer of AtriCure, Inc., acquired 707 shares of common stock through the company's 2018 Employee Stock Purchase Plan.
• The purchase price was $19.35 per share, based on 85% of the closing price of AtriCure's common stock on June 28, 2024, which was $22.77.
• Following this transaction, Dahlquist directly owns 51,661 shares of AtriCure, Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction under the company's employee stock purchase plan. It indicates insider confidence but doesn't provide significant insights into the company's overall performance.

Positives

• Executive participation in the ESPP demonstrates confidence in the company's future.
• The ESPP provides employees with an opportunity to acquire company stock at a discounted rate.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates an executive's participation in a company-sponsored stock purchase plan, which is a common practice.

Comparison to Industry Standards

• Employee Stock Purchase Plans (ESPPs) are a common benefit offered by publicly traded companies, allowing employees to purchase company stock at a discount, typically around 15%.
• The discount offered by AtriCure's ESPP (15%) is in line with industry standards.
• Similar companies like Medtronic and Boston Scientific also offer ESPPs to their employees.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals insider confidence.
• Employees participating in the ESPP benefit from the discounted stock purchase.

Key Dates